Market Monitor: Myriad and Edwards ride out tough start to 2009
This article was originally published in Clinica
Executive Summary
In this new feature, Clinica takes a look at the respective fortunes of publicly-listed medtech players on the international stock exchanges, writes senior business reporter Joseph Harvey. This article focuses on the performance of firms from the beginning of 2009 up until the close of markets on March 27. The regular IPO feature, New Stock Tracker, has been put on hold for the foreseeable future, pending significant movements to report in this field.